课题基金 / 基金详情

The inflammasome and dysfunctional adipose tissue: why should apoB-lipoproteins be targeted in humans

The inflammasome and dysfunctional adipose tissue: why should apoB-lipoproteins be targeted in humans
炎症小体和功能失调的脂肪组织:为什么应将 apoB 脂蛋白作为人类的靶标
批准号:
253614
负责人:
Faraj May
金额:
$52.46万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-03-01 至 2017-03-01

项目摘要

项目成果

Faraj May的其他基金

相关文献

中文摘要
翻译
虽然肥胖会增加患心血管疾病和糖尿病等心脏代谢疾病的风险,但并非所有肥胖者患这些疾病的风险都相同。揭示预测和促进糖尿病的机制对于识别和治疗高血糖至关重要。
英文摘要
While obesity increases the risk for cardiometabolic diseases like cardiovascular disease and diabetes, not all obese are at equal risk for these diseases. Unravelling the mechanisms that predict and promote diabetes is vital to identify and treat the hig
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
White adipose tissue LDL receptors and omega-3 as modulators of the risk for type 2 diabetes
ApoB-lipoproteins, adipose tissue NLRP3 inflammasome and insulin resistance
Targeting hyperapoB vs normoapoB to reduce the risk of type 2 diabetes in obese subjects; mechanism of action
  • 批准号:
    172911
  • 项目类别:
    Operating Grants
  • 资助金额:
    $29.5万
  • 财政年份:
    2008
  • 负责人:
    Faraj May
  • 依托单位: